Lang V, Light PE (2010). “The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes.”. 《Pharmgenomics. Pers. Med.》 (영어) 3: 145–61. doi:10.2147/PGPM.S6969. PMID23226049.
Hoogwerf B, Goetz F (1983). “Urinary C-peptide: a simple measure of integrated insulin production with emphasis on the effects of body size, diet, and corticosteroids”. 《J Clin Endocrinol Metab》 (영어) 56 (1): 60–7. doi:10.1210/jcem-56-1-60. PMID6336620.
Moore C, Cooper G (1991). “Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents”. 《Biochem Biophys Res Commun》 (영어) 179 (1): 1–9. doi:10.1016/0006-291X(91)91325-7. PMID1679326.
Rudenski A, Matthews D, Levy J, Turner R (1991). “Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes”. 《Metabolism》 (영어) 40 (9): 908–17. doi:10.1016/0026-0495(91)90065-5. PMID1895955. CS1 관리 - 여러 이름 (링크)
Lang V, Light PE (2010). “The molecular mechanisms and pharmacotherapy of ATP-sensitive potassium channel gene mutations underlying neonatal diabetes.”. 《Pharmgenomics. Pers. Med.》 (영어) 3: 145–61. doi:10.2147/PGPM.S6969. PMID23226049.
Ido Y, Vindigni A, Chang K; 외. (1997년 7월). “Prevention of vascular and neural dysfunction in diabetic rats by C-peptide”. 《Science》 (영어) 277 (5325): 563–6. PMID9228006.더 이상 지원되지 않는 변수를 사용함 (도움말) CS1 관리 - et al.의 직접적인 사용 (링크) CS1 관리 - 여러 이름 (링크)
Hoogwerf B, Goetz F (1983). “Urinary C-peptide: a simple measure of integrated insulin production with emphasis on the effects of body size, diet, and corticosteroids”. 《J Clin Endocrinol Metab》 (영어) 56 (1): 60–7. doi:10.1210/jcem-56-1-60. PMID6336620.
Moore C, Cooper G (1991). “Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents”. 《Biochem Biophys Res Commun》 (영어) 179 (1): 1–9. doi:10.1016/0006-291X(91)91325-7. PMID1679326.
“U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group”. 《Diabetes》 (영어) 44 (11): 1249–58. 1995년 11월. PMID7589820.더 이상 지원되지 않는 변수를 사용함 (도움말)
Rudenski A, Matthews D, Levy J, Turner R (1991). “Understanding "insulin resistance": both glucose resistance and insulin resistance are required to model human diabetes”. 《Metabolism》 (영어) 40 (9): 908–17. doi:10.1016/0026-0495(91)90065-5. PMID1895955. CS1 관리 - 여러 이름 (링크)
